Reaktionsgleichung
[CH3:1][N:2]1[C:7]([CH3:9])([CH3:8])[CH2:6][C:5](=[N:10][OH:11])[CH2:4][C:3]1([CH3:13])[CH3:12].[CH:14](=O)[C:15]1[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=1>>[C:15]1([CH:14]=[N+:10]([CH:5]2[CH2:6][C:7]([CH3:9])([CH3:8])[N:2]([CH3:1])[C:3]([CH3:13])([CH3:12])[CH2:4]2)[O-:11])[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=1Komponenten
3
Versuchsvorschrift
Following the general procedure of Example 1, the title compound is prepared from 5.0 g (29.4 mmol) of 1,2,2,6,6-pentamethylpiperidin-4-one oxime and 3.1 g [29 mmol) of benzaldehyde in a yield of 2.3 g (30%) of a white solid which after recrystallization from heptane melts at 104°-105° C. 1HMR (200 MHz, CDCl3)δ 8.26 (m, 2H's); 7.45 (s, 1H); 7.40 (m, 3H's); 4.18 (tt, IH); 2.28 (s, 3H's); 2.13 (t, 2H's); 1.93 (dd, 2H's); 1.23 (s, 6H's); 1.10 (s, 6H's). IR (CDCl3) 3020, 2950, 1570, 1550,
Aufarbeitung
- customafter recrystallization from heptane melts at 104°-105° C
Quellen und Nachweise
- ORD-Eintrag
- ord-e07e68c3b14f4afeb76110eca04025c2
- Quelldatensatz
- uspto-grants-1990_11
- Patentnummer
- US04972009
Verknüpfte Notizen
Wird geladen…